ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.49 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PRQR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $159.10M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.62 |
| 52-Week Low | $1.07 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.20.